Radioembolization with Yttrium-90 glass microspheres is a safe and effective treatment for patients with advanced HCC portal vein thrombosis, according to new research. Radioembolisation with ...

Singapore, 10 October 2024 – A study led by clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH) has determined the benefits of ...

BRUSSELS, August 19, 2010 /PRNewswire/ -- Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. The researchers think that having radioembolisation before starting sorafenib may be better ...

Based on New Data from Multi-Centre ENRY Evaluation of 325 Patients, Authors Suggest that Radioembolisation May Be a Well-Tolerated and Effective Option for an Increasing Population of Older Patients ...

SINGAPORE — A new way of treating liver cancer — which combines two existing treatments — is now on trial, with researchers from four medical institutions seeking patients to join the study. The ...

BTG plc, an international specialist healthcare company, announced that the first patient in Malaysia was treated with TheraSphere - a transarterial radioembolisation (TARE) therapy, which targets ...

Hepatocellular carcinoma (HCC) occurs in people whose livers have become severely damaged or cirrhotic, due to conditions such as hepatitis and alcoholism. It is one of the ten most-common cancers in ...

Copenhagen, Denmark, Friday 24 April: Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a safe and effective treatment for patients with advanced HCC ± portal vein thrombosis, according ...

Please note - this trial is no longer recruiting patients. We hope to add results when they are available. The researchers think that having radioembolisation before starting sorafenib may be better ...